FDA Lists Surrogate Endpoints for Drug Sponsors By Sam | July 25, 2018 The FDA on Wednesday published a list for drug sponsors of surrogate endpoints they may consider in trials to support drug approvals or licensures. Source: Drug Industry Daily Posted in Drug Industry Daily